Anticorps Recombinant de lapin anti-VEGFR2/CD309
VEGFR2/CD309 Recombinant Antibody for FC
Hôte / Isotype
Lapin / IgG
Réactivité testée
souris
Applications
FC
Conjugaison
CoraLite® Plus 647 Fluorescent Dye
CloneNo.
240214D7
N° de cat : CL647-98027-2
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en cytométrie | cellules bEnd.3, |
Dilution recommandée
| Application | Dilution |
|---|---|
| This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Informations sur le produit
CL647-98027-2 cible VEGFR2/CD309 dans les applications de FC et montre une réactivité avec des échantillons souris
| Réactivité | souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | Protéine recombinante |
| Nom complet | kinase insert domain protein receptor |
| Masse moléculaire calculée | 150KD |
| Numéro d’acquisition GenBank | NM_010612.2 |
| Symbole du gène | VEGFR-2 |
| Identification du gène (NCBI) | 16542 |
| Conjugaison | CoraLite® Plus 647 Fluorescent Dye |
| Excitation/Emission maxima wavelengths | 654 nm / 674 nm |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS with 0.09% sodium azide |
| Conditions de stockage | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Informations générales
VEGFR2, also named as CD309, KDR and FLK1, is a receptor for VEGF or VEGFC. VEGFR2 which belongs to the protein kinase superfamily, has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. VEGFR2 functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. Mutations of this gene are implicated in infantile capillary hemangiomas.
Protocole
| Product Specific Protocols | |
|---|---|
| FC protocol for CL Plus 647 VEGFR2/CD309 antibody CL647-98027-2 | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
